O4 Hubs detail
O4 Detail Hero Banner
O4 1 Column (Full)
O4 2 Columns (1/4 - 3/4)
O4 Text Component

In this latest Drug Pipeline Insights Report, Optum Rx highlights the four medications expected by the end of the second quarter of 2022. While these new drugs might be safer and more effective, they come at a cost.

The drugs in this report include treatments for:

  • A rare heart condition
  • Plaque psoriasis
  • Type 2 diabetes
  • A cardiovascular disease characterized by an abnormally thick heart muscle

O4 Text Component
O4 Text Component

Don't want to read the full report? Download the brief summary.

O4 Text Component

Related Content

O4 Complex Card

New first-in-class therapies for 2022

View the Optum Rx Drug Pipeline Insights Report for 2022.
O4 Complex Card

5 questions: OptumRx chief pharmacy officer

Michael Einodshofer addresses the risks, challenges and opportunities facing the industry.
O4 Complex Card

The FDA & Alzheimer’s: What’s Next? | OptumRx

Learn how Aduhelm’s approval could impact future drug approvals.

Learn how we can help solve your challenges

Related Content

O4 Complex Card

How new medication packaging helps the planet

New packaging saves CO2, water, energy, and plastic waste.
O4 Complex Card

Reality check: New drugs will cost more

The trend toward complex biologic drugs continues

O4 Complex Card

Forum: Pharmacy care without compromise

Addressing pharmacy issues that matter